
    
      This is a prospective follow-up post-authorization observational study of participants with
      CD and CPF. The study will provide real-world data on how CPF treatments in CD participants
      affect their HRQoL.

      The study will enroll approximately 300 participants. All participants will be enrolled in
      one observational cohort.

      This multi-center trial will be conducted in Spain. The study will collect data from a
      routine medical practice visits for CD participants with CPF and an application that will be
      designed ad hoc and will passively record participant's data. The overall duration of this
      study will be approximately 31 months. Participants will be followed up at Months 6 and 12
      post-treatment.
    
  